Partnership to Improve Prostate Cancer Imaging
|
By HospiMedica staff writers Posted on 03 Jul 2003 |
|
A partnership to promote breakthroughs in prostate cancer imaging has been announced by University Hospitals of Cleveland (OH, USA), Siemens Medical Solutions (Erlangen, Germany), and Cytogen Corp. (Princeton, NJ, USA).
Through this partnership, doctors at the University Hospitals of Cleveland are using the Siemens e.cam gamma camera with Flash 3D iterative reconstruction and computed tomography (CT) attenuation correction technology, in combination with the monoclonal antibody agent ProstaScinet from Cytogen. The resulting images are providing major improvements for the diagnosis and staging of metastatic prostate cancer, according to Bruce Sodee, M.D., professor of radiology, Case Western Reserve University (Cleveland, OH, USA), and a specialist in nuclear medicine at University Hospitals.
In their research, Dr. Sodee and his team are imaging the prostate prior to surgery and then confirming their diagnosis through examination of the specimen after the procedure. He reports they are averaging an accuracy of about 90% in the identification of the tumor location through the imaging procedure, as verified by pathology. In the next step, Dr. Sodee plans to image patients prior to their biopsy, to provide targeting for the urologist performing the biopsy. The final step will be to improve scatter correction in the image, which will help to quantitatively identify exactly how much activity is in the tumor.
"This achievement will help tremendously with prostate cancer research and treatment planning,” said Dr. Sodee.
Related Links:
Siemens Medical
Cytogen
University Hospitals of Cleveland
Through this partnership, doctors at the University Hospitals of Cleveland are using the Siemens e.cam gamma camera with Flash 3D iterative reconstruction and computed tomography (CT) attenuation correction technology, in combination with the monoclonal antibody agent ProstaScinet from Cytogen. The resulting images are providing major improvements for the diagnosis and staging of metastatic prostate cancer, according to Bruce Sodee, M.D., professor of radiology, Case Western Reserve University (Cleveland, OH, USA), and a specialist in nuclear medicine at University Hospitals.
In their research, Dr. Sodee and his team are imaging the prostate prior to surgery and then confirming their diagnosis through examination of the specimen after the procedure. He reports they are averaging an accuracy of about 90% in the identification of the tumor location through the imaging procedure, as verified by pathology. In the next step, Dr. Sodee plans to image patients prior to their biopsy, to provide targeting for the urologist performing the biopsy. The final step will be to improve scatter correction in the image, which will help to quantitatively identify exactly how much activity is in the tumor.
"This achievement will help tremendously with prostate cancer research and treatment planning,” said Dr. Sodee.
Related Links:
Siemens Medical
Cytogen
University Hospitals of Cleveland
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Tourniquet System
heidi– mein Tourniquet
Rapid Sepsis Test
SeptiCyte RAPID
Latest Business News
- Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read more
Critical Care
view channel
Implantable Wireless Light Device Advance Bladder Cancer Treatment
Bladder cancer, a malignancy of the urinary bladder, often requires local therapies that spare surrounding tissue. Photodynamic therapy uses light-activated drugs but is limited by poor light penetration... Read more
AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
Unexplained infertility, diagnosed when routine evaluations identify no clear cause, affects 15–30% of couples and often leaves patients with limited options. Standard testing typically captures hormone... Read more
Surgical Techniques
view channel
BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
